Northeast Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.2M Buy
54,340
+308
+0.6% +$315K 2.4% 12
2026
Q1
$49.7M Buy
54,032
+6
+0% +$6.08K 2.06% 13
2025
Q4
$58.1M Sell
54,026
-116
-0.2% -$111K 2.27% 12
2025
Q3
$41.3M Sell
54,142
-473
-0.9% -$352K 1.66% 15
2025
Q2
$42.6M Sell
54,615
-846
-2% -$657K 1.82% 15
2025
Q1
$45.8M Buy
55,461
+1,983
+4% +$1.65M 2.14% 12
2024
Q4
$41.3M Buy
53,478
+2,226
+4% +$1.84M 1.83% 16
2024
Q3
$45.4M Buy
51,252
+778
+2% +$699K 2.03% 13
2024
Q2
$45.7M Buy
50,474
+3,801
+8% +$3.04M 2.15% 11
2024
Q1
$36.3M Buy
46,673
+5,361
+13% +$3.82M 1.78% 17
2023
Q4
$24.1M Buy
41,312
+5,563
+16% +$3.25M 1.29% 27
2023
Q3
$19.2M Buy
35,749
+6,048
+20% +$3.12M 1.13% 31
2023
Q2
$13.9M Buy
29,701
+12,643
+74% +$5.3M 0.79% 41
2023
Q1
$5.86M Buy
17,058
+975
+6% +$329K 0.36% 56
2022
Q4
$5.88M Buy
16,083
+1,272
+9% +$451K 0.37% 56
2022
Q3
$4.79M Buy
14,811
+1,388
+10% +$440K 0.32% 58
2022
Q2
$4.35M Buy
13,423
+1,873
+16% +$562K 0.28% 62
2022
Q1
$3.31M Buy
11,550
+1,774
+18% +$457K 0.17% 69
2021
Q4
$2.7M Sell
9,776
-606
-6% -$154K 0.13% 77
2021
Q3
$2.4M Sell
10,382
-30
-0.3% -$7.4K 0.13% 85
2021
Q2
$2.39M Sell
10,412
-263
-2% -$52.8K 0.13% 87
2021
Q1
$1.99M Buy
10,675
+75
+0.7% +$14.7K 0.12% 90
2020
Q4
$1.79M Sell
10,600
-65
-0.6% -$9.71K 0.11% 91
2020
Q3
$1.58M Sell
10,665
-17
-0.2% -$2.63K 0.1% 86
2020
Q2
$1.75M Buy
10,682
+88
+0.8% +$13.5K 0.13% 78
2020
Q1
$1.47M Sell
10,594
-395
-4% -$54.3K 0.14% 80
2019
Q4
$1.44M Hold
10,989
0.11% 92
2019
Q3
$1.23M Sell
10,989
-194
-2% -$21.6K 0.1% 97
2019
Q2
$1.24M Sell
11,183
-164
-1% -$19.3K 0.1% 94
2019
Q1
$1.47M Sell
11,347
-112
-1% -$13.6K 0.12% 86
2018
Q4
$1.33M Sell
11,459
-670
-6% -$74.8K 0.13% 88
2018
Q3
$1.3M Hold
12,129
0.1% 92
2018
Q2
$1.03M Sell
12,129
-30
-0.2% -$2.46K 0.09% 99
2018
Q1
$941K Sell
12,159
-690
-5% -$55.5K 0.08% 99
2017
Q4
$1.08M Buy
12,849
+140
+1% +$11.9K 0.09% 96
2017
Q3
$1.09M Hold
12,709
0.1% 94
2017
Q2
$1.05M Hold
12,709
0.1% 94
2017
Q1
$1.07M Hold
12,709
0.1% 95
2016
Q4
$935K Sell
12,709
-459
-3% -$34.2K 0.09% 99
2016
Q3
$1.06M Sell
13,168
-173
-1% -$13.8K 0.11% 96
2016
Q2
$1.05M Hold
13,341
0.11% 93
2016
Q1
$961K Sell
13,341
-496
-4% -$37.5K 0.1% 98
2015
Q4
$1.17M Hold
13,837
0.12% 88
2015
Q3
$1.16M Buy
13,837
+143
+1% +$12.1K 0.13% 90
2015
Q2
$1.14M Sell
13,694
-101
-0.7% -$7.7K 0.12% 95
2015
Q1
$1M Buy
13,795
+35
+0.3% +$2.49K 0.1% 101
2014
Q4
$949K Sell
13,760
-103
-0.7% -$6.95K 0.09% 107
2014
Q3
$899K Buy
13,863
+1,533
+12% +$97.1K 0.09% 108
2014
Q2
$767K Buy
12,330
+2,475
+25% +$148K 0.08% 112
2014
Q1
$580K Buy
9,855
+142
+1% +$7.92K 0.06% 118
2013
Q4
$495K Sell
9,713
-85
-0.9% -$4.26K 0.06% 118
2013
Q3
$493K Sell
9,798
-325
-3% -$17K 0.06% 116
2013
Q2
$497K Buy
+10,123
New +$551K 0.06% 111

Other funds holding LLY

Northeast Investment Management's LLY Position: Q2 2026 in Review

Northeast Investment Management increased its Eli Lilly (LLY) stake by 0.57% in Q2 2026, buying an estimated $315K and bringing the position to 54,340 shares worth $65.2M. The position accounts for 2.4% of the portfolio, ranked #12.

Northeast Investment Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Northeast Investment Management held 54,340 shares of Eli Lilly worth $65.2M as of Q2 2026.
  • Northeast Investment Management bought 308 Eli Lilly shares in Q2 2026, an estimated $315K.
  • Eli Lilly made up 2.4% of Northeast Investment Management's portfolio in Q2 2026, its #12 holding.
  • Northeast Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.